This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AxoGen, Inc. Reports Record Second Quarter 2012 Revenues

AxoGen, Inc. (OTCBB: AXGN):

Second Quarter 2012 Highlights
  • Record revenues of $2.01 million, a 64% increase from second quarter 2011
  • Gross profit for second quarter 2012 increased 89% to a record $1.5 million
  • Gross profit margins improved to 75% compared to 65% for the same period in 2011

AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced revenues for the second quarter ended June 30, 2012 of $2.01 million, a 64% increase over second quarter 2011 revenues of $1.65 million.

“We are pleased to once again have a record quarter,” commented Karen Zaderej, Chief Executive Officer of AxoGen, Inc. “We continue to gain traction in the market by building awareness of our products and I am particularly pleased with the level of receptivity we’re experiencing with surgeons to our entire product portfolio. The handling characteristics and growing body of clinical data continue to drive adoption of Avance® Nerve Graft. In addition, during this quarter we saw solid growth of our AxoGuard® Nerve Protector and AxoGuard® Nerve Connector. AxoGen’s portfolio of products for nerve repair have unique features that are making them the product of choice with many surgeons.”


Revenues for the period were $2.01 million, a 64% increase, compared to $1.23 million in 2011. The improved results were primarily due to improving sales and marketing efforts which have been focused on the development of new accounts as well as improved penetration into key accounts.

Sequentially, revenues improved 22% from the reported first quarter 2012 of $1.65 million.

Gross Profit

Gross profit reached $1.51 million, an 89% increase, for second quarter 2012 up from $0.80 million reported for the same period 2011. The higher gross profit was the result of increased revenues combined with lower manufacturing cost. The gross profit margin increased to 75% compared to 65% for the same quarter last year.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.92 -0.75%
FB $117.78 -0.24%
GOOG $700.54 0.70%
TSLA $212.41 -4.60%
YHOO $36.98 2.70%


Chart of I:DJI
DOW 17,639.18 -12.08 -0.07%
S&P 500 2,048.09 -3.03 -0.15%
NASDAQ 4,716.4350 -9.2040 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs